LD-2 disclosure · 3rd Quarter - Report
ACADIA PHARMACEUTICALS
Client
- Location
- California · United States of America
Registrant
- Description
- Biopharmaceutical company
- Location
- San Diego, California, United States of America
Lobbying activities
4 issuesHealth Issues
Drug pricing issues: H.R. 5376, Inflation Reduction Act of 2022; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236 Department of Defense Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act
Lobbyistsmr MICHAEL MATTOON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Drug Pricing Issues: H.R. 5376, Inflation Reduction Act of 2022; Nursing Home Quality: S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Parkinson's Plan: S. 4851, National Plan to End Parkinsons Act; Six Protected Classes resolution: H. Res. 1390, Expressing support for the protection of Medicare part D's six protected classes
Lobbyistsmr MICHAEL MATTOON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Nursing Home Quality: S. 4659 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; Neurology Research: S. 4661 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023; Rett Syndrome Research: H.R. 8236, Department of Defense Appropriations Act, 2023